E2 ModeratePreliminaryPEM ?Case-ControlPeer-reviewedMachine draft
Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome.
Richards, R S, Roberts, T K, McGregor, N R et al. · Redox report : communications in free radical research · 2000 · DOI
Quick Summary
Researchers compared blood samples from 33 people with ME/CFS and 27 healthy people, looking for signs of oxidative stress—a type of cellular damage caused by unstable molecules called free radicals. They found that people with ME/CFS had higher levels of certain markers of this damage, particularly a substance called methaemoglobin. The levels of these damage markers were strongly linked to how severe patients' symptoms were, including fatigue, pain, sleep problems, and cognitive difficulties.
Why It Matters
This research provides biological evidence that oxidative stress may be a real, measurable component of ME/CFS pathology rather than a purely psychiatric condition. If oxidative stress contributes to symptoms, it could eventually lead to new treatments targeting free radical damage, offering hope for patients who currently have limited therapeutic options.
Observed Findings
- CFS patients had significantly elevated malondialdehyde (P<0.006), methaemoglobin (P<0.02), mean erythrocyte volume (P<0.02), and 2,3-diphosphoglycerate (P<0.04) compared to controls.
- Methaemoglobin levels explained 99% of the variation in overall symptom expression (fatigue, musculoskeletal pain, sleep disturbance).
- Malondialdehyde and 2,3-diphosphoglycerate together explained 99% of variation in cognitive symptoms and sleep disturbance.
- No significant differences were found in standard inflammatory markers (ESR, CRP) between groups.
Inferred Conclusions
- Oxidative stress due to excess free radical formation is a measurable component of ME/CFS pathology.
- Oxidative stress markers correlate strongly with symptom severity and type, suggesting oxidative damage may drive clinical manifestations.
- Methaemoglobin is the principal oxidative stress marker differentiating ME/CFS patients from healthy controls.
Remaining Questions
- Is oxidative stress a primary cause of ME/CFS or a secondary consequence of the disease process?
- Would therapeutic interventions targeting oxidative stress and free radical damage improve symptoms or alter disease progression?
- Do oxidative stress marker levels change over time, and do they correlate with fluctuations in symptom severity?
What This Study Does Not Prove
This study demonstrates association, not causation—we cannot conclude that oxidative stress causes ME/CFS symptoms. It does not establish whether elevated oxidative stress is a primary cause of the disease, a consequence of the illness, or a secondary effect of reduced activity. The small sample size (n=33) and cross-sectional design limit generalizability and cannot determine whether reducing oxidative stress would improve symptoms.
Tags
Symptom:Cognitive DysfunctionUnrefreshing SleepPainFatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:Small SampleExploratory Only
Metadata
- DOI
- 10.1179/rer.2000.5.1.35
- PMID
- 10905542
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026